Cancer Therapy: Preclinical Growth Inhibition of Human Multiple Myeloma Cells by an Oncolytic Adenovirus Carrying the CD40 Ligand Transgene

نویسندگان

  • Debashis Sarker
  • Jae Yeon Chun
  • Nagalakshmi Nadiminty
  • Smitha Dutt
  • Wei Lou
  • Joy C. Yang
  • Hsing-Jien Kung
  • Christopher P. Evans
  • Yolanda Lorenzo
  • Mariano Provencio
  • Luís Lombardía
  • Raquel Díaz
  • Javier Silva
  • Mercedes Herrera
  • Jose M. García
  • Cristina Peña
  • Vanesa García
  • Jesús Romero
  • Gemma Domínguez
  • Menghong Sun
  • Carmen Behrens
  • Lei Feng
  • Natalie Ozburn
  • Ximing Tang
  • Guosheng Yin
  • Ritsuko Komaki
  • Marileila Varella-Garcia
  • Waun Ki Hong
  • Kenneth D. Aldape
  • Hui-Chuan Sun
  • Wei Zhang
  • Xiao-Dong Zhu
  • Peng-Yuan Zhuang
  • Margret S. Fernandes
  • Erica M. Gomes
  • Lindsay D. Butcher
  • Reuben Hernandez-Alcoceba
  • Dongkun Chang
  • Erik E. Johnson
  • Brett H. Yamane
  • Ilia N. Buhtoiarov
  • Hillary D. Lum
  • Alexander L. Rakhmilevich
  • David M. Mahvi
  • Stephen D. Gillies
  • Paul M. Sondel
  • Shawn A. Milligan
  • Patrick Burke
  • David T. Coleman
  • Rebecca L. Bigelow
  • Joshua J. Steffan
  • Jennifer L. Carroll
  • Briana Jill Williams
چکیده

Differential Genetic and Functional Markers of Second Neoplasias in Hodgkin’s Disease Patients. Yolanda Lorenzo, Mariano Provencio, Luís Lombardía, Raquel Díaz, Javier Silva, Mercedes Herrera, Jose M. García, Cristina Peña, Vanesa García, Jesús Romero, Gemma Domínguez, and Félix Bonilla ...............................................................................................................................................4823

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene.

PURPOSE The growth-inhibitory activity of recombinant CD40 ligand (CD40L) is well documented in human multiple myeloma (MM). We examined MM-targeted delivery of CD40L by a conditional replicative oncolytic adenovirus, AdEHCD40L. EXPERIMENTAL DESIGN The growth-regulatory activity of AdEHCD40L was determined in vitro and in vivo. Differential analysis with AdEHCD40L and parental virus (AdEHNull...

متن کامل

Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells.

PURPOSE CD40 ligand (CD40L, CD154) plays a central role in immunoregulation and also directly modulates epithelial cell growth and differentiation. We previously showed that the CD40 receptor is commonly expressed in primary breast cancer tissues. In this proof-of-principle study, we examined the breast cancer growth-regulatory activities of an oncolytic adenoviral construct carrying the CD40L ...

متن کامل

Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.

Among numerous gene therapeutic strategies for cancer treatment, gene transfer by conditionally replicative adenovirus (CRAd) of interferon-gamma (IFN-gamma) may be useful because of the possibility that it will yield IFN-gamma-mediated antiangiogenesis, immune responses, and CRAd-mediated oncolysis. In this study, we constructed a human TERT promoter-mediated oncolytic adenovirus targeting tel...

متن کامل

Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.

Monoclonal antibodies (mAb) directed against lineage-specific B-cell antigens have provided clinical benefit for patients with hematologic malignancies, but to date no antibody-mediated immunotherapy is available for multiple myeloma. In the present study, we assessed the efficacy of a fully human anti-CD40 mAb CHIR-12.12 against human multiple myeloma cells. CHIR-12.12, generated in XenoMouse ...

متن کامل

Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus

Lung cancer stem cell (LCSC) is critical in cancer initiation, progression, drug resistance and relapse. Disadvantages showed in conventional lung cancer therapy probably because of its existence. In this study, lung cancer cell line A549 cells propagated as spheroid bodies (named as A549 sphere cells) in growth factors-defined serum-free medium. A549 sphere cells displayed CSC properties, incl...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009